Valuation: MediPharm Labs Corp.

Capitalization 2.76Cr 2.03Cr 1.71Cr 1.56Cr 1.49Cr 183.54Cr 2.86Cr 18Cr 7.2Cr 88Cr 7.6Cr 7.44Cr 308.81Cr P/E ratio 2025 *
-3.25x
P/E ratio 2026 * -
Enterprise value 2.76Cr 2.03Cr 1.71Cr 1.56Cr 1.49Cr 183.54Cr 2.86Cr 18Cr 7.2Cr 88Cr 7.6Cr 7.44Cr 308.81Cr EV / Sales 2025 *
0.6x
EV / Sales 2026 * 0.55x
Free-Float
94.64%
Yield 2025 *
-
Yield 2026 * -
1 week-7.14%
1 month-13.33%
3 months-7.14%
6 months-13.33%
1 week 0.06
Extreme 0.065
0.07
1 month 0.06
Extreme 0.065
0.08
Current year 0.06
Extreme 0.065
0.08
1 year 0.06
Extreme 0.06
0.12
3 years 0.06
Extreme 0.055
0.12
5 years 0.06
Extreme 0.055
0.83
10 years 0.06
Extreme 0.055
7.39
Manager TitleAgeSince
Chief Executive Officer - 23/01/2026
Chief Tech/Sci/R&D Officer - 01/11/2016
Comptroller/Controller/Auditor - 06/02/2019
Director TitleAgeSince
Director/Board Member - 17/06/2025
Director/Board Member 62 01/04/2023
Director/Board Member - 04/08/2020
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-7.14%0.00%-23.53% 2.03Cr
+0.15%+10.91%+57.38%-33.90% 187.88Cr
-1.25%-6.45%+31.62%+5.71% 109.76Cr
+1.45%-1.41%0.00%+185.71% 55Cr
Average +0.09%-7.59%+22.25%+33.50% 88.66Cr
Weighted average by Cap. -0.08%-4.47%+40.18%+12.46%

Financials

2025 *2026 *
Net sales 4.59Cr 3.37Cr 2.84Cr 2.59Cr 2.47Cr 304.96Cr 4.75Cr 30Cr 12Cr 146.92Cr 13Cr 12Cr 513.1Cr 5.04Cr 3.7Cr 3.12Cr 2.84Cr 2.71Cr 334.91Cr 5.21Cr 33Cr 13Cr 161.35Cr 14Cr 14Cr 563.49Cr
Net income -75.7L -55.53L -46.8L -42.71L -40.77L -50Cr -78.29L -4.96Cr -1.97Cr -24Cr -2.08Cr -2.04Cr -85Cr -19.78L -14.51L -12.23L -11.16L -10.65L -13Cr -20.45L -1.3Cr -51.54L -6.33Cr -54.41L -53.29L -22Cr
Net Debt - -
Logo MediPharm Labs Corp.
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Employees
161
Date Price Change Volume
13/26/13 0.0650 $ 0.00% 9,397
11/26/11 0.0650 $ 0.00% 61,048
10/26/10 0.0650 $ 0.00% 3,09,717
09/26/09 0.0650 $ -7.14% 48,166
06/26/06 0.0700 $ 0.00% 94,716
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0650
Average target price
-

Quarterly revenue - Rate of surprise